History
SEAL Stent-graft
histological study
preclinical study provide histologic evidence for the SEAL product
developers
pioneer and experienced doctors lead development of SEAL stent-graft
bench test for performance
rich and variable bench test for product characteristic and performances
WHO we are
Innovation that excites
we developed stent-graft with 12F delivery system for the first time in the year 2000, and conducted clinical study for this design called “Separate stent-graft for TEVAR and EVAR” at the year 2007 in 44 patients.
Animal study for histologic proof showed complete neointimal covering on the stent-graft product. This is the first animal study which shows ultrathin fabric allow neointimal coverage on it.
developing process
upgrade and improvement for safe and effective procedure
from first development of separate stent-graft, SEAL stent-graft is evolving to achieve better clinical reesults.
1992: Parodi, Montefiore, and the first abdominal aortic aneurysm stent graft in the United States
Technical feasibility and biocompatibility of a newly designed separating stent-graft in the normal canine aorta
- DOI: 10.2214/AJR.05.0683
our
focus
innovation & technology
experience and education
Contact information
82, Bugok-ro, Pogok-up
Choein-gu, Yongin-si, gyeonggi-do, Korea
17023
phone
- TEL ; +82-31-748-6625
- FAX ; +82-31-748-6620